Page last updated: 2024-09-03

(2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine and Vomiting

(2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine has been researched along with Vomiting in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armour, DR; Bays, DE; Evans, B; Giblin, GM; Heron, N; Hubbard, T; Liang, K; Middlemiss, D; Mordaunt, J; Ward, P1
Bountra, C; Dale, TJ; Gale, JD; Gardner, CJ; Jordan, CC; Kilpatrick, GJ; Twissell, DJ; Ward, P1

Other Studies

2 other study(ies) available for (2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine and Vomiting

ArticleYear
Discovery of an orally bioavailable NK1 receptor antagonist, (2S,3S)-(2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (GR203040), with potent antiemetic activity.
    Journal of medicinal chemistry, 1995, Dec-22, Volume: 38, Issue:26

    Topics: Animals; Antiemetics; Biological Availability; Cell Membrane; CHO Cells; Cricetinae; Dogs; Female; Ferrets; Gerbillinae; Magnetic Resonance Spectroscopy; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Tachykinins; Tetrazoles; Vomiting; Whole-Body Irradiation

1995
The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
    British journal of pharmacology, 1995, Volume: 116, Issue:8

    Topics: Animals; Antiemetics; Dogs; Dose-Response Relationship, Drug; Emetics; Ferrets; Male; Motion Sickness; Neurokinin-1 Receptor Antagonists; Piperidines; Radiation Injuries, Experimental; Shrews; Tetrazoles; Vomiting

1995
chemdatabank.com